SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 82 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $6,000 | -40.0% | 11,505 | +1.6% | 0.00% | – |
| Q4 2015 | $10,000 | +25.0% | 11,319 | +9.7% | 0.00% | – |
| Q3 2015 | $8,000 | -74.2% | 10,320 | 0.0% | 0.00% | – |
| Q2 2015 | $31,000 | -92.3% | 10,320 | -93.7% | 0.00% | -100.0% |
| Q1 2015 | $403,000 | +8.9% | 164,374 | +13.3% | 0.00% | – |
| Q4 2014 | $370,000 | -64.2% | 145,060 | +0.3% | 0.00% | -100.0% |
| Q3 2014 | $1,033,000 | +11.1% | 144,634 | +1.4% | 0.00% | 0.0% |
| Q2 2014 | $930,000 | +36.0% | 142,588 | +37.9% | 0.00% | 0.0% |
| Q1 2014 | $684,000 | +60.9% | 103,406 | +15.4% | 0.00% | 0.0% |
| Q4 2013 | $425,000 | -7.2% | 89,568 | -3.0% | 0.00% | 0.0% |
| Q3 2013 | $458,000 | +3.6% | 92,349 | +8.3% | 0.00% | 0.0% |
| Q2 2013 | $442,000 | – | 85,294 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 8,250,000 | $7,404,000 | 3.11% |
| BVF INC/IL | 4,777,381 | $4,288,000 | 0.73% |
| NEA Management Company, LLC | 7,789,644 | $7,011,000 | 0.45% |
| Palo Alto Investors LP | 6,974,854 | $6,260,000 | 0.35% |
| Healthcare Value Capital, LLC | 150,000 | $135,000 | 0.22% |
| Frontier Wealth Management LLC | 527,870 | $474,000 | 0.08% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,067,122 | $1,855,000 | 0.06% |
| Baker Brothers Advisors | 4,450,000 | $3,994,000 | 0.03% |
| Noven Financial Group, Inc. | 41,000 | $37,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 100,000 | $90,000 | 0.02% |